Exercise has been proven safe and effective for patients with breast cancer in the curative setting, however evidence in patients with metastatic breast cancer (mBC) has been lacking. This education session will cover the latest findings relating to role of exercise for the management of metastatic breast cancer, including novel results of the international PREFERABLE - EFFECT Study. The study is the largest exercise study that has been conducted in patients with metastatic breast cancer to date, including 357 patients from five European countries and Australia.
Dr Eva Zopf is an exercise physiologist whose research interest focuses on the role of exercise for the management of cancer. She is a senior research fellow at the Mary MacKillop Institute for Health Research at the Australian Catholic University and Head of the Cancer Exercise Lab at the Cabrini Cancer Institute.
